4//SEC Filing
Praill Anthony Scott 4
Accession 0000905718-19-000759
CIK 0001498382other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:34 PM ET
Size
8.0 KB
Accession
0000905718-19-000759
Insider Transaction Report
Form 4
Praill Scott
CFO
Transactions
- Award
Options (Right to Buy)
2019-09-05+57,170→ 57,170 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (57,170 underlying) - Award
Options (Right to Buy)
2019-09-05+51,196→ 51,196 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (51,196 underlying)
Footnotes (2)
- [F1]Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, 1/6th of the options vest on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020.
- [F2]1/6th of the options vest on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001332948
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:34 PM ET
- Size
- 8.0 KB